marketcaparena

NVCT

Nuvectis Pharma, Inc.

Company overview

Market capitalization
$678.02M
Employees
12
Latest publication
2026-09-29
About Nuvectis Pharma, Inc.

Nuvectis Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology. The company is developing NXP900, a small molecule drug candidate, which is in Phase 1b clinical trial that inhibits the proto-oncogene c-Src and YES1 kinases for treating solid tumors. The company was formerly known as Centry Pharma, Inc. and changed its name to Nuvectis Pharma, Inc. in July 2021. Nuvectis Pharma, Inc. was incorporated in 2020 and is based in Fort Lee, New Jersey.

Company website

Financial statements

Income Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
Total Revenue0USD0USD0USD0USD0USD26,796,000USD0USD0USD
Research Development4,106,000USD5,086,000USD5,774,000USD3,613,000USD3,680,000USD4,496,000USD2,819,000USD2,943,000USD
Selling General Administrative2,154,000USD2,531,000USD2,020,000USD2,982,000USD1,888,000USD1,953,000USD1,540,000USD1,700,000USD
Total Operating Expenses6,260,000USD7,617,000USD7,794,000USD6,595,000USD5,568,000USD6,449,000USD4,359,000USD4,643,000USD
Operating Income-6,260,000USD-7,617,000USD-7,794,000USD-6,595,000USD-5,568,000USD-6,449,000USD-4,359,000USD-4,643,000USD
Interest Income210,000USD303,000USD332,000USD261,000USD236,000USD201,000USD206,000USD215,000USD
Net Interest Income210,000USD303,000USD332,000USD261,000USD236,000USD201,000USD206,000USD215,000USD
Income Before Tax-6,050,000USD-7,314,000USD-7,462,000USD-6,334,000USD-5,332,000USD-6,248,000USD-4,153,000USD-4,428,000USD
Net Income-6,050,000USD-7,314,000USD-7,462,000USD-6,334,000USD-5,332,000USD-6,248,000USD-4,153,000USD-4,428,000USD
Net Income From Continuing Ops-6,050,000USD-7,314,000USD-7,462,000USD-6,334,000USD-5,332,000USD-6,248,000USD-4,153,000USD-4,428,000USD
Ebitda-6,050,000USD-8,210,000USD-7,462,000USD-6,334,000USD-5,332,000USD-6,248,000USD-4,153,000USD-4,428,000USD
Total Other Income Expense Net210,000USD303,000USD332,000USD261,000USD236,000USD201,000USD206,000USD215,000USD
Depreciation And Amortization——7,794,000USD———206,000USD—
Ebit———-6,595,000USD-5,568,000USD-6,449,000USD-4,359,000USD-4,643,000USD
Cost Of Revenue—————13,398,000USD4,359,000USD4,643,000USD
Gross Profit—————13,398,000USD-4,359,000USD-4,643,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Income Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USD
Total Revenue0USD0USD149,000USD0USD—
Research Development18,153,000USD15,380,000USD13,227,000USD9,545,000USD—
Selling General Administrative9,421,000USD7,517,000USD6,007,000USD3,349,000USD24,000USD
Total Operating Expenses27,574,000USD22,897,000USD19,234,000USD12,894,000USD10,000USD
Operating Income-27,574,000USD-22,897,000USD-19,234,000USD-12,894,000USD-10,000USD
Interest Income1,132,000USD475,000USD149,000USD4,000USD—
Net Interest Income1,132,000USD475,000USD149,000USD4,000USD—
Income Before Tax-26,442,000USD-22,260,000USD-19,085,000USD-12,890,000USD-10,000USD
Net Income-26,442,000USD-22,260,000USD-18,787,000USD-12,886,000USD-10,000USD
Net Income From Continuing Ops-26,442,000USD-22,334,000USD-19,234,000USD-12,890,000USD—
Ebitda-26,442,000USD-22,260,000USD-18,936,000USD-12,890,000USD-10,000USD
Total Other Income Expense Net1,132,000USD637,000USD149,000USD4,000USD14,000USD
Cost Of Revenue—22,897,000USD19,234,000USD12,894,000USD—
Gross Profit—-22,897,000USD-19,085,000USD-12,894,000USD—
Selling And Marketing Expenses—14,000USD——9,976USD
Income Tax Expense—1,000USD-298,000USD-4,000USD-24USD
Ebit—-21,897,000USD-19,234,000USD-12,894,000USD-34,000USD
Depreciation And Amortization—-1,000,000USD298,000USD4,000USD24,000USD
Interest Expense——149,000USD4,000USD0USD
Net Income Applicable To Common Shares——-19,085,000USD-12,890,000USD-24,000USD
Other Operating Expenses————10,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
Total Assets25,398,000USD31,709,000USD35,587,000USD27,007,000USD30,148,000USD18,607,000USD17,307,000USD18,298,000USD
Other Current Assets268,000USD75,000USD145,000USD214,000USD284,000USD74,000USD138,000USD182,000USD
Total Liab11,178,000USD13,296,000USD11,577,000USD10,135,000USD9,194,000USD8,894,000USD6,316,000USD5,770,000USD
Total Stockholder Equity14,220,000USD18,413,000USD24,010,000USD16,872,000USD20,954,000USD9,713,000USD10,991,000USD12,528,000USD
Other Current Liab6,519,000USD7,022,000USD5,138,000USD5,158,000USD6,202,000USD6,396,000USD4,337,000USD3,924,000USD
Capital Stock0USD0USD0USD0USD0USD0USD0USD0USD
Retained Earnings-105,737,000USD-99,687,000USD-92,373,000USD-84,911,000USD-78,577,000USD-73,245,000USD-66,997,000USD-62,844,000USD
Cash25,130,000USD31,634,000USD35,442,000USD26,793,000USD29,864,000USD18,533,000USD17,169,000USD18,116,000USD
Cash And Short Term Investments25,130,000USD31,634,000USD35,442,000USD26,793,000USD29,864,000USD18,533,000USD17,169,000USD18,116,000USD
Total Current Assets25,398,000USD31,709,000USD35,587,000USD27,007,000USD30,148,000USD18,607,000USD17,307,000USD18,298,000USD
Total Current Liabilities11,178,000USD13,296,000USD11,577,000USD10,135,000USD9,194,000USD8,894,000USD6,316,000USD5,770,000USD
Net Debt-25,130,000USD-31,634,000USD-35,442,000USD-26,793,000USD-29,864,000USD-18,533,000USD-17,169,000USD-18,116,000USD
Accounts Payable4,695,000USD6,274,000USD6,439,000USD4,977,000USD2,992,000USD2,498,000USD2,261,000USD1,846,000USD
Common Stock Shares Outstanding23,414,475shares21,812,716shares22,719,057shares21,366,268shares19,937,507shares19,495,683shares17,230,559shares16,900,570shares
Non Current Assets Total0USD0USD0USD0USD0USD0USD0USD0USD
Non Current Liabilities Total0USD0USD0USD0USD0USD0USD0USD0USD
Net Working Capital14,220,000USD18,413,000USD24,010,000USD16,872,000USD20,954,000USD9,713,000USD10,991,000USD12,528,000USD
Unclassified Equity119,957,000USD118,100,000USD116,383,000USD101,783,000USD99,531,000USD82,958,000USD77,988,000USD-18,577,316,000USD
Common Stock———————18,652,688,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USD
Total Assets31,709,000USD18,607,000USD19,185,000USD20,405,000USD6,657,000USD6,657,000USD
Other Current Assets75,000USD74,000USD59,000USD412,000USD91,000USD91,000USD
Total Liab13,296,000USD8,894,000USD6,984,000USD6,186,000USD17,665,000USD10,000USD
Total Stockholder Equity18,413,000USD9,713,000USD12,201,000USD14,219,000USD-11,008,000USD-10,000USD
Other Current Liab7,022,000USD6,396,000USD4,213,000USD3,276,000USD1,361,000USD-10,000USD
Capital Stock0USD0USD0USD0USD0USD0USD
Retained Earnings-99,687,000USD-73,245,000USD-54,245,000USD-31,985,000USD-12,900,000USD-10,000USD
Cash31,634,000USD18,533,000USD19,126,000USD19,993,000USD5,742,000USD5,742,000USD
Cash And Short Term Investments31,634,000USD18,533,000USD19,126,000USD19,993,000USD5,742,000USD5,742,000USD
Total Current Assets31,709,000USD18,607,000USD19,185,000USD20,405,000USD5,833,000USD5,833,000USD
Total Current Liabilities13,296,000USD8,894,000USD6,984,000USD6,186,000USD2,419,000USD10,000USD
Net Debt-31,634,000USD-18,533,000USD-19,126,000USD-19,993,000USD-5,742,000USD—
Accounts Payable6,274,000USD2,498,000USD2,771,000USD2,910,000USD1,058,000USD10,000USD
Common Stock Shares Outstanding21,812,716shares17,113,169shares15,556,655shares12,657,651shares12,717,794shares12,717,794shares
Non Current Assets Total0USD0USD0USD0USD824,000USD824,000USD
Non Current Liabilities Total0USD0USD0USD2,910,000USD15,246,000USD10,000USD
Net Working Capital18,413,000USD9,713,000USD12,201,000USD14,219,000USD3,414,000USD-10,000USD
Unclassified Equity118,100,000USD82,958,000USD-17,702,378,000USD46,204,000USD1,892,000USD—
Common Stock——17,768,824,000USD14,752,403,000USD——
Accumulated Other Comprehensive Income———-14,752,403,000USD0USD—
Net Tangible Assets———14,219,000USD-11,008,000USD-10USD
Unclassified Non Current Liabilities———2,910,000USD14,422,000USD—
Deferred Long Term Liab————824,000USD—
Other Assets————824,000USD—
Non Currrent Assets Other————824,000USD—
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USDQ1 20242024-03-31 · USD
Net Income-6,050,000USD-7,314,000USD-6,334,000USD-5,332,000USD-6,248,000USD-4,153,000USD-4,428,000USD-4,171,000USD
Stock Based Compensation-460,000USD1,476,000USD1,731,000USD1,368,000USD1,141,000USD1,159,000USD1,262,000USD1,296,000USD
Other Non Cash Items2,310,000USD1,476,000USD1,731,000USD——2,995,000USD1,175,000USD2,308,000USD
Change In Working Capital-2,311,000USD1,864,000USD1,236,000USD-210,000USD2,642,000USD590,000USD146,000USD-1,483,000USD
Total Cash From Operating Activities-6,511,000USD-3,974,000USD-3,367,000USD-4,174,000USD-2,465,000USD-2,404,000USD-3,020,000USD-4,358,000USD
Capital Expenditures0USD0USD0USD0USD0USD0USD0USD0USD
Free Cash Flow-6,511,000USD-3,974,000USD-3,367,000USD-4,174,000USD-2,465,000USD-2,404,000USD-3,020,000USD-4,358,000USD
Total Cash From Financing Activities7,000USD166,000USD296,000USD15,505,000USD3,829,000USD1,457,000USD1,672,000USD4,696,000USD
Issuance Of Capital Stock7,000USD248,000USD614,000USD16,798,000USD3,953,000USD1,507,000USD1,727,000USD4,849,000USD
Change In Cash-6,504,000USD-3,808,000USD-3,071,000USD11,331,000USD1,364,000USD-947,000USD-1,348,000USD338,000USD
Begin Period Cash Flow31,634,000USD35,442,000USD29,864,000USD18,533,000USD17,169,000USD18,116,000USD19,464,000USD19,126,000USD
End Period Cash Flow25,130,000USD31,634,000USD26,793,000USD29,864,000USD18,533,000USD17,169,000USD18,116,000USD19,464,000USD
Other Cashflows From Financing Activities7,000USD-82,000USD-318,000USD-1,293,000USD-124,000USD-50,000USD-55,000USD-153,000USD
Unclassified Operating Cash Flow—-1,476,000USD-1,731,000USD——-2,995,000USD-1,175,000USD-2,308,000USD
Investments——0USD0USD0USD0USD0USD0USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USD
Net Income-26,442,000USD-19,000,000USD-22,260,000USD-19,085,000USD-12,890,000USD-10,000USD
Stock Based Compensation1,351,000USD4,858,000USD4,705,000USD1,707,000USD1,892,000USD—
Other Non Cash Items4,681,000USD4,995,000USD-139,000USD-2,433,000USD307,000USD24,000USD
Change In Working Capital4,401,000USD1,895,000USD1,740,000USD3,819,000USD1,494,000USD10,000USD
Total Cash From Operating Activities-16,009,000USD-12,247,000USD-15,954,000USD-13,559,000USD-9,504,000USD24,000USD
Capital Expenditures0USD0USD0USD0USD0USD0USD
Free Cash Flow-16,009,000USD-12,247,000USD-15,954,000USD-13,559,000USD-9,504,000USD24,000USD
Total Cash From Financing Activities29,110,000USD11,654,000USD15,087,000USD27,810,000USD15,246,000USD15,246,000USD
Issuance Of Capital Stock31,210,000USD12,036,000USD4,388,000USD31,879,000USD15,246,000USD—
Change In Cash13,101,000USD-593,000USD-867,000USD14,251,000USD5,742,000USD24,000USD
Begin Period Cash Flow18,533,000USD19,126,000USD19,993,000USD5,742,000USD7,214,000USD—
End Period Cash Flow31,634,000USD18,533,000USD19,126,000USD19,993,000USD5,742,000USD24,000USD
Other Cashflows From Financing Activities-2,100,000USD-382,000USD9,798,000USD-4,069,000USD15,246,000USD-4,069,000USD
Investments—0USD0USD0USD0USD—
Unclassified Operating Cash Flow—-4,995,000USD—2,433,000USD——
Change To Liabilities———4,140,000USD1,585,000USD24,000USD
Sale Purchase Of Stock———27,810,000USD——
Cash And Cash Equivalents Changes———14,251,000USD——
Unclassified Financing Cash Flow———4,069,000USD-15,246,000USD19,315,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Operating metrics

No operating metrics are currently published for this company.

Revenue breakdown

No revenue breakdown is currently published for this company.

Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.